About Sanofi/Novartis litigation On March 30,2022 ... and is Phase 3-ready for progressive multiple sclerosis (MS). MN-166 (ibudilast) is also being evaluated in Phase 2 trials in Long COVID and ...

The global auto-injectors market is set to reach a significant valuation of US$ 30,578.2 million in 2023, marking a strong ...

Special hearing: Govt wants consents extended but others want most or all denied.

US President-elect Donald Trump demanded Sunday that Republican lawmakers allow him to appoint key officials without a Senate confirmation vote, aiming to block the little remaining power ...